Health
Abivax's Acquisition Uncertainty Continues Amid Biotech Boom
By Editor • September 3, 2026 • 1 min read
Abivax, a promising French biotech firm, remains unacquired despite expectations of a $20 billion deal, leaving investors concerned.
Read more